PolNet
PolNet enables quantitative analysis of endothelial cell polarity and hemodynamics across entire in vivo vascular networks to study blood flow–driven vascular morphogenesis.
Key Features:
- Image acquisition, segmentation, and analysis protocol: Provides a protocol for acquiring images, segmenting vascular structures, and quantifying endothelial cell polarity across extensive vascular networks.
- Computational Fluid Dynamics (CFD): Integrates computational fluid dynamics to characterize hemodynamics within reconstructed vascular networks.
- Network-level analysis: Performs network-level analyses that link flow metrics to individual endothelial cell polarity and position within the vascular mesh.
- Correlation with cellular and molecular observations: Enables correlation of blood flow dynamics with cellular and molecular experimental observations.
Scientific Applications:
- Endothelial cell polarization and migration: Quantifies endothelial cell polarity and migration patterns in relation to local hemodynamic conditions.
- Vascular patterning and development: Investigates mechanisms underlying vascular development by combining polarity measurements with flow characterization.
- Normal and pathological vessel formation: Explores interactions between cellular polarity and hemodynamic forces to provide insight into normal and pathological morphogenesis.
Methodology:
Image acquisition, segmentation and image analysis combined with computational fluid dynamics (CFD) modeling of flow within reconstructed vascular networks.
Topics
Details
- License:
- LGPL-3.0
- Tool Type:
- desktop application
- Operating Systems:
- Linux, Windows, Mac
- Added:
- 8/4/2018
- Last Updated:
- 11/25/2024
Operations
Publications
Bernabeu MO, Jones ML, Nash RW, Pezzarossa A, Coveney PV, Gerhardt H, Franco CA. PolNet: A Tool to Quantify Network-Level Cell Polarity and Blood Flow in Vascular Remodeling. Biophysical Journal. 2018;114(9):2052-2058. doi:10.1016/j.bpj.2018.03.032. PMID:29742399. PMCID:PMC5961748.
PMID: 29742399
PMCID: PMC5961748
Funding: - Instituto Nacional de Ciência e Tecnologia para Excitotoxicidade e Neuroproteção: EXPL-BEX-BCM-2258-2013, IF/00412/2012, LISBOA-01-0145-FEDER-007391, PRECISE-LISBOA-01-0145-FEDER-016394
- European Research Council: 311719
- British Council: 679368, 692322
- Engineering and Physical Sciences Research Council: EP/L00030X/1
- Cancer Research UK: FC001999
- Fondation Leducq: 17 CVD 03, MR/L016311/1